{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T17:18:01Z","timestamp":1785863881209,"version":"3.56.0"},"reference-count":25,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,8,1]],"date-time":"2020-08-01T00:00:00Z","timestamp":1596240000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,8,1]],"date-time":"2020-08-01T00:00:00Z","timestamp":1596240000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["SFB1328"],"award-info":[{"award-number":["SFB1328"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002347","name":"Bundesministerium f\u00fcr Bildung und Forschung","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002347","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Analytical Biochemistry"],"published-print":{"date-parts":[[2020,8]]},"DOI":"10.1016\/j.ab.2020.113774","type":"journal-article","created":{"date-parts":[[2020,5,20]],"date-time":"2020-05-20T11:15:11Z","timestamp":1589973311000},"page":"113774","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"special_numbering":"C","title":["Recombinant expression of ecto-nucleotide pyrophosphatase\/phosphodiesterase 4 (NPP4) and development of a luminescence-based assay to identify inhibitors"],"prefix":"10.1016","volume":"603","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6364-7755","authenticated-orcid":false,"given":"Vittoria","family":"Lopez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sang-Yong","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Holger","family":"Stephan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christa E.","family":"M\u00fcller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ab.2020.113774_bib1","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1124\/pr.58.1.5","article-title":"Pathophysiology and therapeutic potential of purinergic signalling","volume":"58","author":"Burnstock","year":"2006","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.ab.2020.113774_bib2","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1007\/s11302-012-9309-4","article-title":"Cellular function and molecular structure of ecto-nucleotidases","volume":"8","author":"Zimmermann","year":"2012","journal-title":"Purinergic Signal."},{"key":"10.1016\/j.ab.2020.113774_bib3","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1124\/pr.58.3.3","article-title":"International Union of Pharmacology LVIII: update on the P2Y G protein-coupled nucleotide receptors: from molecular mechanisms and pathophysiology to therapy","volume":"58","author":"Abbracchio","year":"2006","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.ab.2020.113774_bib4","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1124\/pr.110.003129","article-title":"Activation and regulation of purinergic P2X receptor channels","volume":"63","author":"Coddou","year":"2011","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.ab.2020.113774_bib5","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1124\/pr.117.014878","article-title":"The purinergic system as a pharmacological target for the treatment of immune-mediated inflammatory diseases","volume":"71","author":"Antonioli","year":"2019","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.ab.2020.113774_bib6","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1124\/pr.110.003285","article-title":"International Union of Basic and Clinic Pharmacology. LXXXI. Nomenclature and classification of adenosine receptors\u2014an update","volume":"63","author":"Fredholm","year":"2011","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.ab.2020.113774_bib7","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1039\/C7MD00015D","article-title":"Nucleotide pyrophosphatase\/phosphodiesterase 1 (NPP1) and its inhibitors","volume":"8","author":"Lee","year":"2017","journal-title":"MedChemComm"},{"key":"10.1016\/j.ab.2020.113774_bib8","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1016\/j.bbagen.2016.12.019","article-title":"The promiscuous ectonucleotidase NPP1: molecular insights into substrate binding and hydrolysis","volume":"1861","author":"Namasivayam","year":"2017","journal-title":"Biochim. Biophys. Acta Gen. Subj."},{"key":"10.1016\/j.ab.2020.113774_bib9","doi-asserted-by":"crossref","first-page":"3294","DOI":"10.1074\/jbc.M113.505867","article-title":"Molecular basis of purinergic signal metabolism by ectonucleotide pyrophosphatase\/phosphodiesterases 4 and 1 and implications in stroke","volume":"289","author":"Albright","year":"2014","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ab.2020.113774_bib10","doi-asserted-by":"crossref","first-page":"4424","DOI":"10.1038\/s41467-018-06922-7","article-title":"Structural insights into cGAMP degradation by ecto-nucleotide pyrophosphatase phosphodiesterase 1","volume":"9","author":"Kato","year":"2018","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ab.2020.113774_bib11","doi-asserted-by":"crossref","first-page":"4432","DOI":"10.1182\/blood-2012-04-425215","article-title":"NPP4 is a procoagulant enzyme on the surface of vascular endothelium","volume":"120","author":"Albright","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.ab.2020.113774_bib12","first-page":"1","volume":"5","author":"Gorelik","year":"2017"},{"key":"10.1016\/j.ab.2020.113774_bib13","doi-asserted-by":"crossref","first-page":"4189","DOI":"10.1111\/bph.13204","article-title":"Quinazoline-4-piperidine sulfamides are specific inhibitors of human NPP1 and prevent pathological mineralization of valve interstitial cells","volume":"172","author":"Shayhidin","year":"2015","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.ab.2020.113774_bib14","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1007\/s11302-019-09649-2","article-title":"Identification of adenine-N9-(methoxy)ethyl-\u03b2-bisphosphonate as NPP1 inhibitor attenuates NPPase activity in human osteoarthritic chondrocytes","volume":"15","author":"Nassir","year":"2019","journal-title":"Purinergic Signal."},{"key":"10.1016\/j.ab.2020.113774_bib15","doi-asserted-by":"crossref","first-page":"2573","DOI":"10.1111\/jth.12035","article-title":"Modified diadenosine tetraphosphates with dual specificity for P2Y1 and P2Y12 are potent antagonists of ADP-induced platelet activation","volume":"10","author":"Chang","year":"2012","journal-title":"J. Thromb. Haemostasis"},{"key":"10.1016\/j.ab.2020.113774_bib16","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.thromres.2009.11.006","article-title":"Agonist and antagonist effects of diadenosine tetraphosphate, a platelet dense granule constituent, on platelet P2Y1, P2Y12 and P2X1 receptors","volume":"125","author":"Chang","year":"2010","journal-title":"Thromb. Res."},{"key":"10.1016\/j.ab.2020.113774_bib17","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/j.ejmech.2015.10.055","article-title":"New highly active antiplatelet agents with dual specificity for platelet P2Y1 and P2Y12 adenosine diphosphate receptors","volume":"107","author":"Yanachkov","year":"2016","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ab.2020.113774_bib18","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.bcp.2014.11.002","article-title":"Polyoxometalates - potent and selective ecto-nucleotidase inhibitors","volume":"93","author":"Lee","year":"2015","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.ab.2020.113774_bib19","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/S0014-5793(03)00272-2","article-title":"Firefly luciferase is a bifunctional enzyme: ATP-dependent monooxygenase and a long chain fatty acyl-CoA synthetase","volume":"540","author":"Oba","year":"2003","journal-title":"FEBS Lett."},{"key":"10.1016\/j.ab.2020.113774_bib20","doi-asserted-by":"crossref","first-page":"5206","DOI":"10.1111\/j.1742-4658.2005.04895.x","article-title":"Coenzyme A affects firefly luciferase luminescence because it acts as a substrate and not as an allosteric effector","volume":"272","author":"Fraga","year":"2005","journal-title":"FEBS J."},{"key":"10.1016\/j.ab.2020.113774_bib21","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/j.trac.2004.04.001","article-title":"Trends in quality in the analytical laboratory. II. Analytical method validation and quality assurance","volume":"23","author":"Taverniers","year":"2004","journal-title":"TrAC Trends Anal. Chem."},{"key":"10.1016\/j.ab.2020.113774_bib22","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1177\/108705719900400206","article-title":"A simple statistical parameter for use in evaluation and validation of high throughput screening assays","volume":"4","author":"Zhang","year":"1999","journal-title":"J. Biomol. Screen"},{"key":"10.1016\/j.ab.2020.113774_bib23","doi-asserted-by":"crossref","first-page":"473","DOI":"10.3109\/10409238.2014.953627","article-title":"Enzymes involved in metabolism of extracellular nucleotides and nucleosides: functional implications and measurement of activities","volume":"49","author":"Yegutkin","year":"2014","journal-title":"Crit. Rev. Biochem. Mol. Biol."},{"key":"10.1016\/j.ab.2020.113774_bib24","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1039\/b719181b","article-title":"Firefly luminescence: a historical perspective and recent developments","volume":"7","author":"Fraga","year":"2008","journal-title":"Photochem. Photobiol. Sci."},{"key":"10.1016\/j.ab.2020.113774_bib25","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1021\/ja01318a036","article-title":"The determination of enzyme dissociation constants","volume":"56","author":"Lineweaver","year":"1934","journal-title":"J. Am. Chem. Soc."}],"container-title":["Analytical Biochemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003269720303067?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003269720303067?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,2]],"date-time":"2025-11-02T11:58:33Z","timestamp":1762084713000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0003269720303067"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8]]},"references-count":25,"alternative-id":["S0003269720303067"],"URL":"https:\/\/doi.org\/10.1016\/j.ab.2020.113774","relation":{},"ISSN":["0003-2697"],"issn-type":[{"value":"0003-2697","type":"print"}],"subject":[],"published":{"date-parts":[[2020,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Recombinant expression of ecto-nucleotide pyrophosphatase\/phosphodiesterase 4 (NPP4) and development of a luminescence-based assay to identify inhibitors","name":"articletitle","label":"Article Title"},{"value":"Analytical Biochemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ab.2020.113774","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"113774"}}